The treatment of Heart Health & Pigmentary Glaucoma with vitamins

Heart Health and Pigmentary Glaucoma: Mitamins custom make quality formulas for the treatment of Heart Health & Pigmentary Glaucoma with vitamins. A Heart Health & Pigmentary Glaucoma formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Heart Health and Pigmentary Glaucoma

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Thiamin
    50
    mg
    3333%
    Magnesium
    25
    mg
    6%
    Zinc
    10
    mg
    67%
    Alpha Lipoic Acid
    50
    mg
    *
    CoQ-10
    30
    mg
    *
    Omega - 3 Fatty Acids
    100
    mg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    100
    mg
    *
    Hawthorn Extract
    100
    mg
    *
    L-Arginine
    250
    mg
    *
    L-Carnitine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Heart Health and Pigmentary Glaucoma
Serving Size:4-5

Heart Health and Pigmentary Glaucoma Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
World's Mental Health Care Needs Not Being Met, Global Survey Finds
Mental disorders rank among the top ten illnesses causing disability -- more than 37 percent worldwide -- with depression being the leading cause of disability among people ages 15 and older, according to the Global Burden of Disease and Risk Factors published in 2006.
New Schizophrenia Drug Shows Promise In Phase II Human Trials
A new experimental drug for the treatment of schizophrenia which targets glutamate receptors in the brain rather than dopamine has shown promise in human trials. The volunteers experienced significant improvements in their symptoms while suffering few side effects. The drug is currently called "LY2140023".You can read about this trial in an article published in Nature Medicine.
This information concerning the support of Heart Health and Pigmentary Glaucoma treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments